HCA Announces Special Dividend of $2.50 per Share and Record and Payment Dates

  HCA Announces Special Dividend of $2.50 per Share and Record and Payment

Business Wire

NASHVILLE, Tenn. -- October 23, 2012

HCA Holdings, Inc. (NYSE: HCA) today announced that its Board of Directors has
approved a special cash dividend of $2.50 per share to be paid to shareholders
of record as of November 2, 2012 with a payment date of November 16, 2012. The
dividend is expected to be funded through borrowings under the Company’s
credit facilities.

“We believe a special dividend provides a cash return to our shareholders
while not affecting our ability to continue to invest in our markets and make
acquisitions. Also, the impact of this dividend on the Company’s leverage will
be modest,” stated R. Milton Johnson, HCA President and Chief Financial

Cautionary Statement - Forward-Looking Information

This press release contains forward-looking statements based on current
management expectations. Those forward-looking statements include all
statements other than those made solely with respect to historical fact,
including statements with respect to the approved special dividend. Numerous
risks, uncertainties and other factors may cause actual results to differ
materially from those expressed in any forward-looking statements. These
factors include, but are not limited to, (1) the impact of the special
dividend, (2) the impact of our substantial indebtedness and the ability to
refinance such indebtedness on acceptable terms, (3) the effects related to
the enactment and implementation of the Budget Control Act of 2011 and the
Patient Protection and Affordable Care Act, as amended by the Health Care and
Education Reconciliation Act (collectively, the “Health Reform Law”), the
possible enactment of additional federal or state health care reforms and
possible changes to the Health Reform Law and other federal, state or local
laws or regulations affecting the health care industry, (4) increases in the
amount and risk of collectability of uninsured accounts and deductibles and
copayment amounts for insured accounts, (5) the ability to achieve operating
and financial targets, and attain expected levels of patient volumes and
control the costs of providing services, (6) possible changes in the Medicare,
Medicaid and other state programs, including Medicaid upper payment limit
programs or Waiver Programs, that may impact reimbursements to health care
providers and insurers, (7) the highly competitive nature of the health care
business, (8) changes in service mix, revenue mix and surgical volumes,
including potential declines in the population covered under managed care
agreements, the ability to enter into and renew managed care provider
agreements on acceptable terms and the impact of consumer driven health plans
and physician utilization trends and practices, (9) the efforts of insurers,
health care providers and others to contain health care costs, (10) the
outcome of our continuing efforts to monitor, maintain and comply with
appropriate laws, regulations, policies and procedures, (11) increases in
wages and the ability to attract and retain qualified management and
personnel, including affiliated physicians, nurses and medical and technical
support personnel, (12) the availability and terms of capital to fund the
expansion of our business and improvements to our existing facilities, (13)
changes in accounting practices, (14) changes in general economic conditions
nationally and regionally in our markets, (15) future divestitures which may
result in charges and possible impairments of long-lived assets, (16) changes
in business strategy or development plans, (17) delays in receiving payments
for services provided, (18) the outcome of pending and any future tax audits,
appeals and litigation associated with our tax positions, (19) potential
adverse impact of known and unknown government investigations, litigation and
other claims that may be made against us, (20) our ongoing ability to
demonstrate meaningful use of certified electronic health record technology
and recognize income for the related Medicare or Medicaid incentive payments,
and (21) other risk factors described in our annual report on Form 10-K for
the year ended December 31, 2011 and our other filings with the Securities and
Exchange Commission. Many of the factors that will determine our future
results are beyond our ability to control or predict. In light of the
significant uncertainties inherent in the forward-looking statements contained
herein, readers should not place undue reliance on forward-looking statements,
which reflect management’s views only as of the date hereof. We undertake no
obligation to revise or update any forward-looking statements, or to make any
other forward-looking statements, whether as a result of new information,
future events or otherwise.

All references to “Company” and “HCA” as used throughout this release refer to
HCA Holdings, Inc. and its affiliates.


HCA Holdings, Inc.
Investor Contact:
Mark Kimbrough, 615-344-2688
Media Contact:
Ed Fishbough, 615-344-2810
Press spacebar to pause and continue. Press esc to stop.